Sign in

NCT04364854CompletedPhase 2

Speech Entrainment for Aphasia Recovery

Source: ClinicalTrials.gov · Last updated 14 Nov 2025

Brief summary (registry, in English)

After a stroke, many people experience a language impairment called aphasia. One of the most debilitating types of aphasia is non-fluent aphasia. Non-fluent aphasia is defined by significantly reduced speech production, with the speaker producing only a few words or even less. Speech entrainment therapy (SET) is a treatment that has been shown to increase fluency in people with non-fluent aphasia. The study looks to define the best dose of SET that leads to sustained improvements in spontaneous speech production. Participants who are eligible will undergo baseline language testing, an MRI, and will be randomized into one of 4 treatment groups: SET for 3 weeks, SET for 4.5 weeks, SET for 6 weeks, and no treatment (control group).

Status (registry)
Completed
Phase (registry)
Phase 2
Study type
Interventional
Enrollment
80 (actual)
First submitted
23 Apr 2020
Start date
21 Aug 2020
Primary completion date
8 May 2024
Lead sponsor
Medical University of South Carolina
Diseases
Stroke
NCT number
NCT04364854

What you commit to

  • Study type: Interventional · Phase 2
  • Participants enrolled: 80
  • From 21 Aug 2020 to the primary completion date, 8 May 2024
  • 3 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study design.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • History of chronic neurological or psychiatric diseases (excluding migraines, depression, or post-stroke epilepsy). Self-reported history of learning disability.
  • History of right-hemisphere strokes or brain stem/cerebellar strokes with persistent deficits (as evidenced by MRI/CT and NIHSS).

Other

  • Severe dysarthria (determined via SLP clinical judgment from spontaneous speech tasks on the ASRS 3.0).
  • Global aphasia.
  • Uncorrectable hearing as determined by the SLP's clinical judgment.
  • Uncorrectable vision.
  • Contraindications to MRI or inability to complete the MRI scanning session.
  • Women who are pregnant.

Who the study is looking for

  • Aphasia as a result of a left hemisphere ischemic or hemorrhagic stroke (WAB-R Aphasia Quotient \<93.8).
  • Presence of left hemisphere stroke in clinical imaging (CT/MRI) and NIHSS
  • Participants must have spoken English as their primary language.
  • 21-81 years old
  • Pre-stroke modified Rankin Scale (mRS)= 2 or less
  • Post-stroke mRS= 4 or less.
  • At least 6 months post-stroke.
  • Non-fluent aphasia (WAB-R Comprehension score \>4 and WAB-R Fluency score \<6).
  • Technological compatibility (to be determined by clinical judgment of SLP)

Age in the registry: 21 years to 81 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (3)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Medical University of South Carolina
Coordinator of this site? Confirm its status
CharlestonUnited StatesUnknown status
University of South Carolina
Coordinator of this site? Confirm its status
ColumbiaUnited StatesUnknown status
University of Utah
Coordinator of this site? Confirm its status
Salt Lake CityUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.